Anocca
Södertälje
About Anocca
Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptors to treat infectious and autoimmune diseases. The company does precise and efficient analysis of T-cell biology, which is required to deliver a variety of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas, including cancer, assisting the life sciences sector in developing a variety of therapies and vaccination strategies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $156.4M
- Last round: Series Unknown (Aug 2025)
- Website: anocca.com
- Phone: 46841080757
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/anocca-29063 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.